Role of interleukin 23 signaling in clostridium difficile colitis

Journal of Infectious Diseases

Volumn 208, Issue 6, 2013, Pages 917-920

  Buonomo, Erica L ^a   Madan, Rajat ^b   Pramoonjago, Patcharin ^c   Li, Li ^b   Okusa, Mark D ^b   Petri, William A ^a,b,c  

^a Immunology   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Clostridium difficile; colitis; interleukin 23 (IL 23); Interleukin 10; lamina propria; mucosal immunity; nosocomial; Th17 cytokines, enteric

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; INTERLEUKIN 23;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CLOSTRIDIUM DIFFICILE INFECTION; COLON BIOPSY; COLONY FORMING UNIT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION;

CLOSTRIDIUM DIFFICILE; COLITIS; INTERLEUKIN 23 (IL-23); INTERLEUKIN-10; LAMINA PROPRIA; MUCOSAL IMMUNITY; NOSOCOMIAL; TH17 CYTOKINES, ENTERIC;

ANIMALS; BIOPSY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-23; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPECIMEN HANDLING;

EID: 84883226853     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit277     Document Type: Conference Paper

References (15)

1. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the Healthcare System. Clin Infect Dis 2012; 55:S88-S92.
2. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2010; 8:17-26.
3. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9.
4. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th-17 cell-mediated pathology. Nat Immunol 2007; 8:1390-7.
5. Ahern PP, Schiering C, Buonocore S, et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010; 33:279-88.
6. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-25.
7. Langrish CL. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40.
8. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-6.
9. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008; 57:1682-9.
10. Chen X, Katchar K, Goldsmith JD, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008; 135:1984-92.
11. Warren CA, Van Opstal E, Ballard TE, et al. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrob Agents Chemother 2012; 56:4103-11.
12. Sandborn WJ, Gasink C, Gao L, et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012; 367:1519-28.
13. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10:479-89.
14. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011; 34:149-62.
15. Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464:1371-5.